Latest Breaking News On - Panbela therapeutics - Page 1 : comparemela.com

Contrasting ProPhase Labs (NASDAQ:PRPH) and Panbela Therapeutics (NASDAQ:PBLA)

ProPhase Labs (NASDAQ:PRPH – Get Free Report) and Panbela Therapeutics (NASDAQ:PBLA – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations. Profitability This table compares ProPhase Labs and […]

PBLA Stock Earnings: Panbela Therapeutics Misses EPS for Q1 2024

Panbela Therapeutics, Inc. (NASDAQ:PBLA) Q1 2024 Earnings Call Transcript

Operator: Good afternoon, everyone, and welcome to the Panbela Therapeutics First Quarter 2024 Earnings Call. [Operator Instructions].

Panbela Therapeutics' (PBLA) "Neutral" Rating Reaffirmed at HC Wainwright

Panbela Therapeutics (NASDAQ:PBLA – Get Free Report)‘s stock had its “neutral” rating restated by investment analysts at HC Wainwright in a research report issued to clients and investors on Thursday, Benzinga reports. Separately, Roth Mkm reiterated a “buy” rating on shares of Panbela Therapeutics in a research note on Wednesday, March 27th. Get Our Latest […]

Panbela Therapeutics Updates ASPIRE Trial Timeline

An update from Panbela Therapeutics (PBLA) is now available. Panbela Therapeutics, Inc. has announced an update on the expected timeline for the in.